The proposed renewal is for a continuation of the Biology of Infectious Diseases Training Program to train physician-scientists in infectious diseases-related translational research, both clinical and laboratory-based. The program draws on the laboratory and clinical research skills and resources of a broad group of faculty addressing questions directly relevant to infectious diseases. Funding is requested for four postdoctoral trainees per year, primarily MDs or MD/PhDs, recruited the UCSF Infectious Diseases Fellowship Program, but also PhD postdoctoral trainees from research faculty laboratories. We continue to improve our efforts to recruit underrepresented minorities and women into the program. The main program is a hands-on research experience under the close supervision of a research mentor and a career development committee selected on the basis of the research interests and goals of the trainee. Research may be at the molecular, cellular, whole animal, clinical, or population levels. Educational and training opportunities have been created to prepare individuals for research and leadership positions in academic medicine, public health, or industry in the areas of epidemiology, public health, global health, HIV/AIDS, genomics, antimicrobial resistance, microbial pathogenesis and host response, and immunology. The educational program provides for special courses, small group conferences, research conferences and seminars, coursework in immunology, microbial pathogenesis, biostatistics, epidemiology, study design, scientific writing, and ethics of scientific conduct. Emphasis is placed on personal instruction specifically designed for individual trainees and on multidiscipline interactions. The quality and effectiveness of the program is measured by the success of our trainees in 1) completion of fellowship training, 2) the number and quality of publications in peer-reviewed journals and research presentations, 3) obtaining research funding (e.g., independent research awards, K-awards or equivalent career-development awards, R01-level or equivalent awards), and 4) attainment of a research-oriented career as medical school faculty, in industry, or in the public health sector.
Infectious diseases are the third most common cause of death in the United States, despite availability of antibiotics, vaccines, and high standards of public health and the leading cause of death worldwide. Our program supports the training of young scientists that will address high impact research questions aimed at improving our knowledge, treatment, control, and prevention of infectious diseases.
|Langelier, Charles; Christenson, Stephanie A (2016) An Expression of Clinical Significance: Exploring the Human Genome to Understand the Variable Response to Rhinovirus. Am J Respir Crit Care Med 193:710-2|
|Solomon, Marc M; Schechter, Mauro; Liu, Albert Y et al. (2016) The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B. J Acquir Immune Defic Syndr 71:281-6|
|Solomon, Marc M; Mayer, Kenneth H (2015) Evolution of the syphilis epidemic among men who have sex with men. Sex Health 12:96-102|
|Solomon, Marc M; NureÃ±a, CÃ©sar R; Tanur, Judith M et al. (2015) Transactional sex and prevalence of STIs: a cross-sectional study of MSM and transwomen screened for an HIV prevention trial. Int J STD AIDS 26:879-86|
|Sears, David; Mpimbaza, Arthur; Kigozi, Ruth et al. (2015) Quality of inpatient pediatric case management for four leading causes of child mortality at six government-run Ugandan hospitals. PLoS One 10:e0127192|
|Rosenberg, Oren S; Dovala, Dustin; Li, Xueming et al. (2015) Substrates Control Multimerization and Activation of the Multi-Domain ATPase Motor of Type VII Secretion. Cell 161:501-12|
|Vijayan, Tara; Zheng, Patricia; Nguyen, Cynthia et al. (2015) Survey of Asian patients with hepatitis B infection: limited knowledge of transmission and screening of family members. J Immigr Minor Health 17:112-7|
|Gose, Severin O; Soge, Olusegun O; Beebe, James L et al. (2015) Failure of azithromycin 2.0 g in the treatment of gonococcal urethritis caused by high-level resistance in California. Sex Transm Dis 42:279-80|
|Sserwanga, Asadu; Sears, David; Kapella, Bryan K et al. (2015) Anti-malarial prescription practices among children admitted to six public hospitals in Uganda from 2011 to 2013. Malar J 14:331|
|Stoltey, Juliet E; Li, Ye; Bernstein, Kyle T et al. (2015) Ecological analysis examining the association between census tract-level incarceration and reported chlamydia incidence among female adolescents and young adults in San Francisco. Sex Transm Infect 91:370-4|
Showing the most recent 10 out of 47 publications